Trials / Completed
CompletedNCT05560529
Dialectical Behavioral Therapy As A Therapeutic Tool In Patients With Binge Eating Disorder
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Binge eating disorder (BED) is one of the recently acknowledged eating disorders, with many theories underlying its pathology whether biological or psychological. From the biological perspective, changes in plasma ghrelin were hypothesized to have a major role in developing and maintaining the disorder, while from the psychopathological perspectives, abnormalities in emotion regulation were found in many patients. Since Dialectical Behavioral Therapy (DBT) is known to target emotion dysregulation, the main aim of this study is to assess the efficacy of DBT versus treatment as usual (TAU) in BED patients, and whether plasma ghrelin level will be affected after treatment in both arms.
Detailed description
Binge eating disorder (BED) is one of the recently acknowledged eating disorders, with many theories underlying its pathology whether biological or psychological. From the biological perspective, changes in plasma ghrelin were hypothesized to have a major role in developing and maintaining the disorder, while from the psychopathological perspectives, abnormalities in emotion regulation were found in many patients. Since Dialectical Behavioral Therapy (DBT) is known to target emotion dysregulation, the main aim of this study is to assess the efficacy of DBT versus treatment as usual (TAU) in BED patients, and whether plasma ghrelin level will be affected after treatment in both arms, with patients being randomly allocated in both groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | DBT | Applying DBT modules in group format over 20 weeks |
| DRUG | TAU | Giving TAU (usual pharmacotherapy in BED) over 20 weeks |
| DIAGNOSTIC_TEST | Plasma Ghrelin | Measuring fasting plasma ghrelin pre and post treatment in both arms |
Timeline
- Start date
- 2023-03-15
- Primary completion
- 2024-06-15
- Completion
- 2024-09-15
- First posted
- 2022-09-29
- Last updated
- 2025-01-29
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05560529. Inclusion in this directory is not an endorsement.